Volume 17, Number 10—October 2011
Perspective
Global Spread of Carbapenemase-producing Enterobacteriaceae
Patrice Nordmann
, Thierry Naas, and Laurent Poirel
, Thierry Naas, and Laurent Poirel
Table 2
Breakpoint values (MIC, mg/L) for carbapenems according to guidelines in Europe (EUCAST) and the United States (CLSI), September 2010*
| Carbapenem | EUCAST | CLSI | |||
|---|---|---|---|---|---|
| S | R | S | R | ||
| Ertapenem | <0.5 | >1 | <0.25 | >1 | |
| Imipenem | <2 | >8 | <1 | >4 | |
| Meropenem | <2 | >8 | <1 | >4
*EUCAST, European Committee on Antimicrobial Susceptibility Testing (www.eucast.org/clinical_breakpoints); CLSI, Clinical and Laboratory Standards Institute; S, sensitive; R, resistant. *EUCAST, European Committee on Antimicrobial Susceptibility Testing (www.eucast.org/clinical_breakpoints); CLSI, Clinical and Laboratory Standards Institute; S, sensitive; R, resistant. | |
*EUCAST, European Committee on Antimicrobial Susceptibility Testing (www.eucast.org/clinical_breakpoints); CLSI, Clinical and Laboratory Standards Institute; S, sensitive; R, resistant.
Page created: September 19, 2011
Page updated: September 19, 2011
Page reviewed: September 19, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.